Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer

Open access
Högemann-Savellano, Dagmar, Bos, Erik, Blondet, Cyrille, Sato, Fuminori, Abe, Tatsuya, Josephson, Lee, Weissleder, Ralph, Gaudet, Justin, Sgroi, Dennis, Peters, Peter J., Basilion, James P.·2003·Neoplasia

Abstract

Noninvasive imaging of differences between the molecular properties of cancer and normal tissue has the potential to enhance the detection of tumors. Because overexpression of endogenous transferrin receptor (TfR) has been qualitatively described for various cancers and is presumably due to malignant transformation of cells, TfR may represent a suitable target for application of molecular imaging technologies to increase detection of smaller tumors. In the work reported here, investigation into the biology of this receptor using electron microscopy has demonstrated that iron oxide particles targeted to TfR are internalized and accumulate in lysosomal vesicles within cells. Biochemical analysis of the interaction of imaging probes with cells overexpressing the TfR demonstrated that the extent of accumulation, and therefore probe efficacy, is dependent on the nature of the chemical cross-link between transferrin and the iron oxide particle. These data were utilized to design and synthesize an improved imaging probe. Experiments demonstrate that the novel magnetic resonance imaging (MRI) probe is sensitive enough to detect small differences in endogenous TfR expression in human cancer cell lines. Quantitative measurement of TfR overexpression in a panel of 27 human breast cancer patients demonstrated that 74% of patient cancer tissues overexpressed the TfR and that the sensitivity of the new imaging agent was suitable to detect TfR overexpression in greater than 40% of these cases. Based on a biochemical and cell biological approach, these studies have resulted in the synthesis and development of an improved MRI probe with the best in vitro and in vivo imaging properties reported to date.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1476-5586(03)80034-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 201

Metadata

Authors
Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., & Basilion, J. P.
Venue
Neoplasia
Publisher
Elsevier BV
Published
2003-11
Volume
5
Issue
6
Pages
495-506
ISSN
1476-5586 (ISSN-L)
OpenAlex
W2155976768
Cited by
201
References
2
FWCI
5.12
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer. https://app.cochat.ai/papers/10.1016/s1476-5586(03)80034-9
The paper
Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., & Basilion, J. P. (2003). The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer. Neoplasia. https://doi.org/10.1016/s1476-5586(03)80034-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.